Evidence map›Paper›PMID 42564569›Full record

ArticleBlood neoplasia2026

Expression of RUNX1::RUNX1T1 deregulates the proteome, induces C/EBPβ suppression, and blocks myeloid differentiation.

Aleksandra Azevedo, Adam Leckenby, Rachael Nicholson, Ana Catarina Menezes, Sara Davies, Amanda F Gilkes, Sarah Baker, Raymond Toghill, Ellie McCracken, Andrew Pierce and 4 more

Abstract read
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Aleksandra AzevedoDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Adam LeckenbyDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Rachael NicholsonDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Ana Catarina MenezesDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Sara DaviesDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Amanda F GilkesDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Sarah BakerDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Raymond ToghillDepartment of Haematology, University Hospital of Wales, Cardiff, United Kingdom.
Ellie McCrackenDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Andrew PierceStem Cell and Leukaemia Proteomics Laboratory, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Bethany GearyProteomics Platform, UK Dementia Research Institute, University of Dundee, Dundee, United Kingdom.
Anthony D WhettonVeterinary Health Innovation Engine, School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom.
Richard L DarleyDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Alex TonksDivision of Cancer and Genetics, Department of Haematology, School of Medicine, Cardiff University, Cardiff, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of RUNX1::RUNX1T1 (also known as RUNX1::ETO) is frequently observed in acute myeloid leukemia (AML) and has been shown to block myeloid development. Although several studies have shown RUNX1::RUNX1T1 transcriptional deregulation, the proteome in human hematopoietic stem and progenitor cells (HSPCs) is poorly characterized. Using mass spectrometry, we show that expression of RUNX1::RUNX1T1 in human HSPCs was linked to differential expression of 257 proteins, including CCAAT/enhancer-binding protein beta (C/EBPβ) downregulation. Consistent with this observation, although

Identifiers

PMID42564569
PMCPMC13443899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.